| Jan 14, 2026 | Vista.ai | $29.5M Series B | — | Bold Brain Ventures, Maureen (Klewicki) Burgess, Fox Chase Cancer Center, Blake Gardner, Bruce Armstrong, TGH Ventures, University of Utah |
| Oct 1, 2025 | Foundation Health | $20.0M Series A | Define Ventures | Calm/Storm Ventures, Y Combinator, Vanderbilt University |
| Oct 1, 2025 | knownwell | $26.0M Series B | Alyssa Reisner | Andreessen Horowitz, Flare Capital Partners, Larry Summers, Varsha Rao, Geoff Price, Andreessen Horowitz, Sheralee Petersen, MassMutual |
| Sep 30, 2025 | Visana Health | $24.0M Series A | — | Cigna Ventures, Flare Capital Partners, Frist Cressey Ventures |
| Sep 4, 2025 | Octave Bioscience | $51.1M Debt / Series C | — | BlueCross BlueShield Venture Partners, Brook Byers, Casdin Capital, Hikma Ventures, Merck, Northpond Ventures, Novartis, Section 32, Silicon Valley Bank, Valhalla Charitable Foundation |
| Feb 15, 2024 | Freenome | $254.0M Other Equity | Matt Sause | American Cancer Society, Andreessen Horowitz, ARK Invest, ArrowMark Partners, Bain Capital Life Sciences, Data Collective, Eventide Asset Management, Perceptive Advisors, Polaris Partners, Pura Vida Investments, Mark A. Gardner, RA Capital Management, Sands Capital, Section 32, Squarepoint Capital, T. Rowe Price Associates |
| Sep 1, 2023 | Cylinder | $31.0M Series B | Health Catalyst Capital | 7wire Ventures, Digitalis Ventures, Hubrix Ventures, Mercato Partners, L.D. Salmanson, Distributed Ventures, Human Capital, SemperVirens |
| Jul 26, 2023 | Octave Bioscience | $30.0M Series B Extension | Michael Rubin | Julian Harris, BlueCross BlueShield Venture Partners, Brook Byers, Casdin Capital, Deerfield Management, Echo Health Ventures, Lana Ghanem, Nickolas Mark, Merck, Northpond Ventures, Novartis, Rana Lonnen, Section 32 |
| Jun 2, 2023 | Axuall, Inc. | $20.0M Series B | Ryan Collins | Ajay Kumar, AV8 Ventures, Epsilon Health Investors, Flare Capital Partners, Ajay Kumar, InHealth Ventures, JumpStart Ventures, Chris Franklin, M25, UH Ventures |
| Apr 1, 2023 | CTRL Therapeutics | $10.0M Seed | General Catalyst | ARCH Venture Partners, F-Prime Capital Partners, FTX Ventures, Lux Capital, Mubadala, Y Combinator, Arash Ferdowsi, Balaji Srinivasan, Eoghan McCabe, Karim Atiyeh, Scott Belsky, FACIT |
| Nov 1, 2022 | Maven Clinic | $90.0M Series E | General Catalyst | Addition, Andreessen Horowitz, Dragoneer Investment Group, Forerunner Ventures, Khosla Ventures, Lux Capital, Mischief Venture Capital, Next Ventures, Operator Partners, Sequoia Capital, SV Angel, Y Combinator, Vivek Garipalli, CVS Health Ventures, Icon Ventures, La Famiglia, Oak HC/FT |
| Mar 1, 2022 | Cylinder | $16.0M Series A | 7wire Ventures | Digitalis Ventures, Hubrix Ventures, L.D. Salmanson, Big Pi Ventures, Elements Health Ventures, Human Capital, Leaps by Bayer, LifeForce Capital, NFP Ventures, SemperVirens |
| Jan 1, 2022 | Transcarent | $200.0M Series C | Kinnevik, Armaan Ali | 7wire Ventures, General Catalyst, Frederique Dame, Ingeborg Investments, Lightspeed Venture Partners, Lux Capital, Maveron, McCarthy Capital, OMERS Ventures, Red Swan Ventures, SuperAngel.Fund, The Food Loft, Tiffany, Town Hall Ventures, Vouch Insurance, XFactor Ventures, Alison Pincus, Brian Sugar, Elliott Cohen, Fidji Simo, Henry Davis, Jason Starr, Jon Stein, Lev Ekster, Nik Sharma, Ally Bridge Group, Alta Partners, GreatPoint Ventures, Jove Equity Partners, Merck, Michael Dowling, Rush University Medical Center, Threshold Ventures |
| Dec 1, 2021 | Freenome | $300.0M Series D | Ellen Hukkelhoven, Peter Kolchinsky | Anzu Partners, Ameena El-Bibany, Vasudev Bailey, Artis Ventures (AV), Asset Management Ventures, Bain Capital Life Sciences, Cofounders Capital, Merck Global Health Innovation Fund, Polaris Partners, RA Capital, Section 32, Anne Wojcicki, Timothy A. Springer, Andreessen Horowitz, ArrowMark Partners, BrightEdge Ventures, Byers Capital, Catalio Capital Management, Data Collective, Eventide Asset Management, Farallon Capital Management, Fidelity Management & Research Company, Google Ventures, HBM Healthcare Investments, Janus Henderson Investors, Kaiser Permanente, Logos Capital, Novartis, Polaris Partners, Pura Vida Investments, Ridgeback Capital Investments, Thomas Schinecker, Rock Springs Capital, Sands Capital, Soleus Capital, Suvretta Capital Management, T. Rowe Price Associates |
| Jul 13, 2021 | Axuall, Inc. | $10.4M Series A | Michael Greeley | AV8 Ventures, Epsilon Health Investors, InHealth Ventures, Nickolas Mark, JumpStart, M25, MedStar Health, North Coast Ventures, David Sylvan |
| Dec 24, 2020 | SomaLogic | $81.0M Series A Extension | Eli Casdin | Amgen Ventures, Boston Millennia Partners, Farallon Capital Management, Fiscus Ventures, Foresite Capital, Janus Henderson Investors, Logos Capital, Madryn Asset Management, Monashee Investment Management, Mossrock Capital, NEC Solution Innovators, Novartis, Redmile Group, Reimagined Ventures, Revelation Partners, Soleus Capital, Roy Smythe, T. Rowe Price Associates, Ziff Capital Partners |
| Sep 10, 2020 | Recursion | $239.0M Series D | Juergen Eckhardt | Advantage Capital, Casdin Capital, Catalio Capital Management, Data Collective, Epic Ventures, Felicis Ventures, Laurion Capital Management, Lux Capital, Obvious Ventures, Samsara BioCapital, Two Sigma Ventures |
| Sep 1, 2020 | Recursion Pharmaceuticals | $240.0M Series D | Juergen Eckhardt | 01 Advisors, Album VC, Dimension Capital, Advantage Capital, Casdin Capital, Catalio Capital Management, Epic Ventures, Felicis Ventures, Laurion Capital Management, Lux Capital, Obvious Ventures, Samsara BioCapital, Two Sigma Ventures |
| Jul 1, 2020 | GYANT | $14.0M Series A | Wing Venture Capital | ALPANA Ventures, Fyrefly VC, General Catalyst, Insight Partners, Maximon, Therese Liechtenstein, Grazia Equity, Michael Phillips, MD, MBA, Plug and Play Ventures, Techstars |
| Jul 1, 2020 | Thrive Earlier Detection | $260.0M Series B | Section 32, Eli Casdin | Acrew Capital, CRV, GreatPoint Ventures, Mubadala, Polaris Partners, Third Rock Ventures, Trucks Venture Capital, VZVC, Bain Capital Life Sciences, Brown Advisory, Driehaus Capital Management, Janus Henderson Investors, Lux Capital, Perceptive Advisors, Rock Springs Capital, Sands Capital, T. Rowe Price Associates |
| May 28, 2020 | Syapse Inc. | $30.0M Other Equity | Zack Scott | Amgen Ventures, Ascension Ventures, Merck, Roche Finance, Safeguard Scientifics, Social Capital |
| Jul 15, 2019 | Recursion | $121.0M Series C | — | AME Cloud Ventures, CRV, Data Collective, Epic Ventures, Felicis Ventures, Lux Capital, Mubadala Capital, Obvious Ventures, Texas Tech University System, Two Sigma Ventures, University of Minnesota |
| Jul 1, 2019 | Recursion Pharmaceuticals | $120.0M Series C | — | 01 Advisors, Album VC, Dimension Capital, Gaingels, Menlo Ventures, AME Cloud Ventures, CRV, Data Collective, Epic Ventures, Felicis Ventures, Lux Capital, Mubadala Capital, Obvious Ventures, Texas Tech University System, Two Sigma Ventures, University of Minnesota |
| Apr 1, 2019 | Redox | $33.0M Series C | Battery Ventures | Headwater Ventures, RRE Ventures, Duncan Gills, .406 Ventures |
| Jun 1, 2018 | Zebra Medical Vision | $30.0M Series C | — | ACME Capital, AIX Ventures, Dell Technologies Capital, DNX Ventures, Founders Fund, Khosla Ventures, Menlo Ventures, OurCrowd, Polychain Capital, Phil Libin, Shervin Pishevar, Fei-Fei Li, Richard Socher, Morris Kahn, Dolby Family Ventures, Johnson & Johnson Innovation, NVIDIA |
